Source: BioPortfolio

Nutrinia: Nutrinia Raises $30M to Continue Development of Specialized Oral Insulin

NewsNutrinia will use the proceeds to initiate two pivotal trials for registration in separate indications related to acceleration of gut maturation and adaptationT

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
CEO Avatar

CEO

Michael Olshansky

CEO Approval Rating

70/100

Read more